Benitec Biopharma Inc. Logo

Benitec Biopharma Inc.

A clinical-stage biotech developing genetic medicines to silence disease-causing genes.

BNTC | US

Overview

Corporate Details

ISIN(s):
US08205P2092
LEI:
Country:
United States of America
Address:
3940 TRUST WAY, 94545 HAYWARD

Description

Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the development of novel genetic medicines. The company utilizes its proprietary DNA-Directed RNA Interference (ddRNAi) platform, which combines gene therapy with RNA interference (gene silencing) to create treatments. This technology is designed to permanently silence disease-causing genes. Benitec's therapeutic programs target chronic and life-threatening human diseases that are gene-associated and for which there are currently no effective treatments or cures.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Benitec Biopharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Benitec Biopharma Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Benitec Biopharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Astria Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for allergic and immunologic diseases.
United States of America
ATXS
ATAI Life Sciences N.V. Logo
Develops psychedelic-inspired therapies for mental health disorders.
United States of America
ATAI
Atea Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing oral antiviral therapies for serious viral diseases.
United States of America
AVIR
Athira Pharma, Inc. Logo
Biopharma firm developing small molecule therapeutics for neurodegenerative diseases.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharmaceutical company developing oncology medicines for breast cancer.
United States of America
ATOS
aTYR PHARMA INC Logo
Develops medicines based on tRNA synthetase biology for fibrosis and inflammation.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Develops Virus-Like Drug Conjugates as targeted therapies for solid tumors.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharmaceutical company developing therapies for severe autoimmune diseases.
United States of America
AUPH
AURORA CANNABIS INC Logo
Global producer and distributor of cannabis for medical and recreational markets.
United States of America
ACB
Autolus Therapeutics plc Logo
Biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases.
United States of America
AUTL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.